PLAA anticorps (AA 101-200)

N° du produit ABIN704411

Détail du produit anti-PLAA anticorps

Antigène: PLAA (Phospholipase A2-Activating Protein (PLAA))

Épitope: AA 101-200

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLAA est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Phospholipase A2 activator protein

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Références pour anticorps anti-PLAA (ABIN704411)

Rosing, Fobker, Kannenberg, Gunia, DellAquila, Kwiecien, Stypmann, Nofer: "Everolimus therapy is associated with reduced lipoprotein-associated phospholipase A2 (Lp-Pla2) activity and oxidative stress in heart transplant recipients." dans: Atherosclerosis, Vol. 230, Issue 1, pp. 164-70, (2013) (PubMed).

Détails sur PLAA

Antigène: PLAA (Phospholipase A2-Activating Protein (PLAA))

Autre désignation: PLAA/Phospholipase A2 activator protein (PLAA Produits)

Synonymes: anticorps cb623, anticorps zgc:56568, anticorps zgc:66193, anticorps wu:fc45d08, anticorps wu:fi33e06, anticorps PLAA, anticorps doa1, anticorps pla2p, anticorps plap, anticorps DOA1, anticorps PLA2P, anticorps PLAP, anticorps 2410007N06, anticorps AI536418, anticorps AU018445, anticorps AW208417, anticorps D4Ertd618e, anticorps Ufd3, anticorps Plap, anticorps phospholipase A2-activating protein, anticorps phospholipase A2 activating protein, anticorps phospholipase A2-activating protein L homeolog, anticorps phospholipase A2-activating protein S homeolog, anticorps phospholipase A2, activating protein, anticorps plaa, anticorps PLAA, anticorps plaa.L, anticorps plaa.S, anticorps Plaa

Sujet:

Synonyms: DOA1, PLAP, PLA2P, Phospholipase A-2-activating protein, PLAA

Background: Phospholipase A2 activator protein (PLAP), activates PLA2 (phospholipase A2 enzyme) and is an important mediator of eicosanoid generation. Also known as a pro-inflammatory agent, PLAP has been found in inflamed tissues and synovial fluid from patients with rheumatoid arthritis. As such, it is believed to play an important role in the regulation of inflammatory diseases. The formation of PLAP can be stimulated by IL-1 beta and TNF-alpha.

ID gène: 9373

UniProt: Q9Y263